OMF Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Pullback HYLN Q1 2026 Earnings Narrowerthanexpected loss fuels significant stock surge ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending CXW Q1 2026 Earnings Strong EPS Beat Amidst Mixed Market Reaction PHGE Q4 2025 Earnings Severe EPS Miss as BiomX Continues Clinical Development Power REIT PW Q2 2025 Earnings Positive EPS Reported as Stock Gains Ground